AAF
BIIB icon

Andra AP-fonden’s Biogen BIIB Stock Holding History

Andra AP-fonden’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.53M Buy
52,000
+49,500
+1,980% +$9.12M 0.11% 208
2025
Q4 		$440K Buy
+2,500
New +$408K 0.01% 397
2025
Q3 		– Sell
-22,400
Closed -$2.81M – 421
2025
Q2 		$2.81M Sell
22,400
-23,800
-52% -$2.97M 0.04% 323
2025
Q1 		$6.32M Buy
46,200
+12,500
+37% +$1.79M 0.1% 263
2024
Q4 		$5.15M Buy
33,700
+7,000
+26% +$1.18M 0.08% 291
2024
Q3 		$5.18M Buy
26,700
+2,300
+9% +$481K 0.08% 298
2024
Q2 		$5.66M Buy
24,400
+3,600
+17% +$782K 0.1% 276
2024
Q1 		$4.49M Sell
20,800
-10,200
-33% -$2.39M 0.08% 286
2023
Q4 		$8.02M Sell
31,000
-1,000
-3% -$246K 0.42% 101
2023
Q3 		$8.22M Sell
32,000
-5,200
-14% -$1.39M 0.48% 73
2023
Q2 		$10.6M Sell
37,200
-23,100
-38% -$6.88M 0.27% 85
2023
Q1 		$16.8M Buy
60,300
+10,100
+20% +$2.79M 0.44% 15
2022
Q4 		$13.9M Buy
50,200
+11,400
+29% +$3.22M 0.42% 16
2022
Q3 		$10.4M Sell
38,800
-11,400
-23% -$2.42M 0.34% 44
2022
Q2 		$10.2M Buy
+50,200
New +$10.3M 0.29% 75
2021
Q4 		$14.5M Sell
60,400
-3,100
-5% -$797K 0.3% 78
2021
Q3 		$18M Buy
63,500
+4,400
+7% +$1.44M 0.37% 17
2021
Q2 		$20.5M Buy
59,100
+6,300
+12% +$1.91M 0.42% 4
2021
Q1 		$14.8M Sell
52,800
-6,200
-11% -$1.67M 0.33% 22
2020
Q4 		$14.4M Buy
59,000
+23,100
+64% +$5.96M 0.32% 22
2020
Q3 		$10.2M Sell
35,900
-700
-2% -$195K 0.28% 64
2020
Q2 		$9.79M Buy
36,600
+4,100
+13% +$1.23M 0.28% 22
2020
Q1 		$10.3M Buy
32,500
+2,800
+9% +$850K 0.37% 3
2019
Q4 		$8.81M Sell
29,700
-2,300
-7% -$638K 0.25% 28
2019
Q3 		$7.45M Sell
32,000
-3,100
-9% -$722K 0.22% 85
2019
Q2 		$8.21M Buy
35,100
+5,500
+19% +$1.27M 0.24% 49
2019
Q1 		$7M Buy
+29,600
New +$9.32M 0.2% 143
2018
Q3 		$11.7M Sell
33,000
-1,900
-5% -$654K 0.3% 20
2018
Q2 		$10.1M Buy
34,900
+7,100
+26% +$2M 0.27% 31
2018
Q1 		$7.61M Buy
27,800
+15,900
+134% +$4.94M 0.2% 161
2017
Q4 		$3.79M Sell
11,900
-3,100
-21% -$994K 0.09% 365
2017
Q3 		$4.7M Sell
15,000
-3,700
-20% -$1.1M 0.11% 282
2017
Q2 		$5.07M Buy
18,700
+1,400
+8% +$370K 0.13% 238
2017
Q1 		$4.73K Buy
17,300
+600
+4% +$170K 0.11% 267
2016
Q4 		$4.74M Buy
16,700
+1,000
+6% +$296K 0.13% 240
2016
Q3 		$4.92M Hold
15,700
– – 0.13% 234
2016
Q2 		$3.8M Sell
15,700
-700
-4% -$184K 0.1% 314
2016
Q1 		$4.27M Sell
16,400
-400
-2% -$106K 0.11% 261
2015
Q4 		$5.15M Sell
16,800
-400
-2% -$115K 0.15% 177
2015
Q3 		$5.02M Hold
17,200
– – 0.15% 194
2015
Q2 		$6.95M Sell
17,200
-100
-0.6% -$40.1K 0.2% 144
2015
Q1 		$7.3M Sell
17,300
-5,900
-25% -$2.33M 0.21% 137
2014
Q4 		$7.88M Hold
23,200
– – 0.18% 163
2014
Q3 		$7.67M Buy
23,200
+300
+1% +$98.9K 0.18% 178
2014
Q2 		$7.22M Sell
22,900
-28,000
-55% -$8.43M 0.16% 212
2014
Q1 		$15.6M Sell
50,900
-8,700
-15% -$2.76M 0.36% 65
2013
Q4 		$16.7M Sell
59,600
-4,700
-7% -$1.22M 0.39% 54
2013
Q3 		$15.5M Sell
64,300
-700
-1% -$157K 0.39% 51
2013
Q2 		$14M Buy
+65,000
New +$13.9M 0.36% 48

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Andra AP-fonden's BIIB Position: Q1 2026 in Review

Andra AP-fonden increased its Biogen (BIIB) stake by 1,980% in Q1 2026, buying an estimated $9.12M and bringing the position to 52,000 shares worth $9.53M. The position accounts for 0.11% of the portfolio, ranked #208.

Andra AP-fonden first reported a position in BIIB in Q2 2013 and has held it in 49 quarters since. The position peaked at $20.5M in Q2 2021. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Andra AP-fonden held 52,000 shares of Biogen worth $9.53M as of Q1 2026.
  • Andra AP-fonden bought 49,500 Biogen shares in Q1 2026, an estimated $9.12M.
  • Biogen made up 0.11% of Andra AP-fonden's portfolio in Q1 2026, its #208 holding.
  • Andra AP-fonden first reported a position in Biogen in Q2 2013 and has held it in 49 quarters since.
  • Andra AP-fonden's Biogen position peaked at $20.5M in Q2 2021.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.